Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd Live Price Chart
Performance
| Previous Close | ₹ 40.97 |
| High | ₹ 41 |
| Volume | 69000 |
| 52W Range | ₹ 33 - ₹ 60 |
| Open | ₹ 40.99 |
| Low | ₹ 40 |
| Market Cap | ₹ 36.6 Cr |
Goldline Pharmaceutical Ltd Technicals
| 20 Day | ₹ 40.355 |
| 50 Day | ₹ 41.928 |
| 100 Day | ₹ 42.740 |
| 200 Day | ₹ 42.740 |
| 20 Day | ₹ 40.408 |
| 50 Day | ₹ 41.177 |
| 100 Day | ₹ 48.418 |
| 200 Day | ₹ 58.310 |
Goldline Pharmaceutical Ltd Fundamentals
| ROCE | 28.352 |
| P/E Ratio | 0.000 |
| P/B Ratio | 1.600 |
| Industry P/E | 1.600 |
| Debt to Equity | 51.376 |
| ROE | 28.893 |
| EPS | 0.000 |
| Dividend Yield | 0.000 |
| Book Value | 25.055 |
| Face Value | 10.000 |
Goldline Pharmaceutical Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 |
|---|---|---|---|---|
| Total Revenue | 31.1987 | 28.0557 | 23.566 | 19.8485 |
| Total Expenses | 25.8133 | 24.1973 | 21.0391 | 19.4471 |
| Profit After Tax | 4.1171 | 2.8342 | 1.806 | 0.2566 |
Goldline Pharmaceutical Ltd Shareholding Pattern
| Promoter Holdings | 57.292 % |
| FIIs | 5.156 % |
| DIIs | 7.813 % |
| MutualFund | 0.000 % |
| Retail | 25.136 % |
| Others - | 4.604 % |
About Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company w.e.f. September 23, 2013. The Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 8 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. The Company launched the IPO comprising a fresh issue of 27,00,000 Equity shares of Rs 10 each and raised funds of Rs 11.61 crore on 14 May 2026. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.71 +1.54 (+3.57%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 510.00 -5.35 (-1.04%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,100.00 -6.25 (-0.09%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 616.40 +29.35 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,900.00 -395.7 (-1.5%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,416.00 -2 (-0.14%) |
FAQs on Goldline Pharmaceutical Ltd
1. Can I buy Goldline Pharmaceutical Ltd from PL Capital? ›
2. Does Goldline Pharmaceutical Ltd pay dividends? ›
3. What is the current share price of Goldline Pharmaceutical Ltd ? ›
4. What is the 52-week high and low of Goldline Pharmaceutical Ltd ? ›
Start SIP in Goldline Pharmaceutical Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
